Trusted News Discovery Since 2008
{{/content}}
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine
Video Credit: ANI
Published on September 15, 2020 - Duration: 01:21s
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine
Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India.
He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance.
He said, "3 vaccines are at clinical trial stage in India.
Cadila and Bharat Biotech have completed phase-I trials.
Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."
You are here
Related news from verified sources
The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India, began at the...
on September 21, 2020 • IndiaTimes
Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the US biotech firm's potential Covid-19 vaccine and it expects to begin...
on September 22, 2020 • IndiaTimes
Related videos from verified sources
New promising results from Moderna vaccine trial 00:21
Video credit: KTNV Channel 13 Las Vegas - Published on September 30, 2020
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister 02:29
Video credit: HT Digital Content - Published on September 30, 2020
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials 02:37
Video credit: The Street - Published on September 30, 2020